Etonogestrel/ethinylestradiol vaginal ring - Evestra

Drug Profile

Etonogestrel/ethinylestradiol vaginal ring - Evestra

Alternative Names: EVE-112

Latest Information Update: 21 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Evestra
  • Developer Evestra; Gedeon Richter; Research Center Pharmaceutical Engineering
  • Class Alkylated estrogenic steroids; Contraceptives; Hormonal contraceptives; Norpregnanes; Norpregnatrienes; Progesterone congeners
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Pregnancy

Most Recent Events

  • 06 Mar 2017 Chemical structure information added
  • 10 Sep 2016 Phase-III clinical trials in Pregnancy (Prevention) in Bulgaria and Poland (Vaginal) (EudraCT2016-002092-10)
  • 27 Jan 2016 Phase-II clinical trials in Pregnancy (Prevention) in Germany (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top